Market Tracker

03/24 5:16pm ET

PDL BioPharma Inc (NASDAQ:PDLI)

1.98
Delayed Data
As of Mar 24
 -0.05 / -2.46%
Today’s Change
1.93
Today|||52-Week Range
3.84
-6.60%
Year-to-Date
No recent news for PDL BioPharma Inc.

Today’s Trading

Previous close2.03
Today’s open2.02
Day’s range1.96 - 2.04
Volume1,708,004
Average volume (3 months)2,500,365
Market cap$327.8M
Dividend yield10.11%
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-80.79%
Earnings growth (this year)-68.38%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)-59.03%
P/E ratio5.1
Price/Sales1.45
Price/Book0.44

Competitors

 Today’s
change
Today’s
% change
BLCMBellicum Pharmaceuti...-0.86-6.67%
GERNGeron Corp+0.01+0.47%
AGENAgenus Inc-0.04-1.02%
ONVOOrganovo Holdings In...+0.02+0.66%
Data as of 3:59pm ET, 03/24/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)$0.02
Annual revenue (last year)$239.7M
Annual profit (last year)$63.6M
Net profit margin26.54%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts